Cancer Research Articles

Melody Chang, RPh, MBA, BCOP, director of pharmacy operations for Florida Cancer Specialists & Research Institute (FCS), has published an article concerning the ongoing controversy surrounding the treatment of cancer patients with medical marijuana or other cannabinoid-derived products.

Florida Cancer Specialists & Research Institute (FCS) physicians are the co-authors of 20 research studies that will be presented at the American Society of Clinical Oncology (ASCO®) ASCO20 Virtual Scientific Program being held May 29 – 31, 2020.

Despite the many challenges of the current health care crisis, patients of  Florida Cancer Specialists & Research Institute (FCS) report high satisfaction with the oncology provider’s response and efforts to provide care safely, and with little or no disruption.

Advanced radiation therapy options lead to faster and shorter rounds of radiation therapy for patients with certain types of cancer.

Florida Cancer Specialists & Research Institute (FCS) recently launched telehealth services across all FCS sites statewide, allowing patients continued and convenient access to care, while mitigating the impact and spread of COVID-19. This virtual care solution plays a vital role in response to the pandemic crisis, maintaining patient access to care directly from home. FCS was among the first cancer care groups in Florida to launch telehealth resources to cancer patients during the pandemic.

Today we cut the ribbon to celebrate our new FCS Lake Mary Cancer Center and Sarah Cannon Research Institute Drug Development Unit at FCS!

Florida Cancer Specialists & Research Institute (FCS) will expand access to comprehensive cancer treatment and opportunities for patients to participate in cutting-edge cancer research with the opening of its FCS Cancer Center and Sarah Cannon Research Institute Drug Development Unit in Lake Mary later this month.

Florida Cancer Specialists & Research Institute (FCS) has met the accreditation standards required by the Better Business Bureau for membership and has received the organization’s A+ rating.